Linagliptin inhibits lipopolysaccharide-induced inflammation in human U937 monocytes.

Abstract

BACKGROUND:

Atherosclerosis and inflammation are more common in patients with diabetes than in patients without diabetes, and atherosclerosis progression contributes to inflammation. Therefore, anti-inflammatory therapy is important for the prognosis of patients with diabetes. Linagliptin is the only bile-excreted, anti-diabetic oral dipeptidyl peptidase-4 (DPP-4) inhibitor. Although the anti-inflammatory effects of DPP-4 inhibitors in vivo and in vitro have been reported, few in vitro studies have examined the effects of linagliptin using monocytes, which play a central role in arteriosclerosis-related inflammation. Herein, we assessed the anti-inflammatory effects of linagliptin in human U937 monocytes.

METHODS:

U937 cells at densities of 1 × 106 cells/mL were cultured in Roswell Park Memorial Institute medium supplied with 10% fetal bovine serum and treated with 100 nM phorbol myristate acetate for 48 h for differentiation into macrophages. The media were replaced, and the cells were pretreated with 1, 5, 10, 50, and 100 nM linagliptin for 1 h or were left untreated. The media were then replaced again, and the cells were treated with 1 μg/mL lipopolysaccharide (LPS) or 10 nM interleukin (IL)-1β only, in combination with 1, 5, 10, 50, and 100 nM linagliptin or were left untreated. The extracted media were used to measure IL-6 and tumor necrosis factor (TNF)-α levels using enzyme-linked immunosorbent assay kits.

RESULTS:

LPS alone significantly increased IL-6 and TNF-α production compared with the control treatment. The treatment of cells with linagliptin at all concentrations significantly inhibited the LPS-stimulated IL-6 and TNF-α production. Meanwhile, IL-1β alone significantly increased IL-6 production compared with the control treatment. No significant difference in IL-6 production was noted between the cells treated with IL-1β and simultaneous treatment with IL-1β and linagliptin.

CONCLUSIONS:

Linagliptin inhibited LPS-induced inflammation in human monocytic U937 cells.

• Authors: Shiho Yamadera, Yuya Nakamura, Masahiro Inagaki, Sachiyo Kenmotsu, Tetsuhito Nohara, Naoki Sato, Tatsunori Oguchi, Mayumi Tsuji, Isao Ohsawa, Hiromichi Gotoh, Yoshikazu Goto, Akihiko Yura, Yuji Kiuchi, Shinichi Iwai
• Journal: Inflammation and regeneration (Inflamm Regen) Vol. 38 Pg. 13 ( 2018) ISSN: 1880-9693 [Print] England
• PMID: 30151063 (Publication Type: Journal Article)